1. Ambrus, J. L., Ambrus, C. M., Gastpar, H., Huberman, E., Montagna, R., Biddle, W., Leong, S., andHoroszewicz, J., 1982,Interaction of Platelets and Tumor Cells.Progress in Clinical and Biological Research (New York: Alan R. Liss, Inc.), pp. 97–108.
2. Ambrus, J. L., Ambrus, C. M., andGastpar, H., 1978, Studies on platelet aggregationin vivo. VI. Effect of pyrimido-pyrimidine derivative (RA 233) on tumor cell metastasis.Journal of Medicine,9, 183–186.
3. Belloni, P. N., andNicolson, G. L., 1988, Differential expression of cell surface glycoproteins on organ-derived murine vascular endothelia and endothelial cells.Journal of Cellular Physiology, in press.
4. Biddle, W., Montagna, R. A., Leong, S. S., Horoszewics, J., Gastpar, H., andAmbrus, J. L., 1984, Antineoplastic effect of the pyrimido-pyrimidine derivative: RA 233.Pathology and Biology,32, 9–13.
5. Cucuianu, M. P., Nishizawa, E. E., andMustard, J. F., 1971, Effect of pyrimido-pyrimidine compounds on platelet function.Journal of Laboratory Medicine,77, 958–974.